5VOF
DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban
Summary for 5VOF
Entry DOI | 10.2210/pdb5vof/pdb |
Descriptor | Coagulation factor X, DNA/RNA (36-MER), 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, ... (8 entities in total) |
Functional Keywords | serine protease, blood coagulation, aptamer, inhibitor, hydrolase-hydrolase inhibitor-rna complex, hydrolase/hydrolase inhibitor/rna |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 3 |
Total formula weight | 43876.33 |
Authors | Krishnaswamy, S.,Kumar, S. (deposition date: 2017-05-02, release date: 2018-06-13, Last modification date: 2023-10-04) |
Primary citation | Gunaratne, R.,Kumar, S.,Frederiksen, J.W.,Stayrook, S.,Lohrmann, J.L.,Perry, K.,Bompiani, K.M.,Chabata, C.V.,Thalji, N.K.,Ho, M.D.,Arepally, G.,Camire, R.M.,Krishnaswamy, S.,Sullenger, B.A. Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass. Nat. Biotechnol., 36:606-613, 2018 Cited by PubMed: 29863725DOI: 10.1038/nbt.4153 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.25 Å) |
Structure validation
Download full validation report